As of June 16, 2025, Imagion Biosystems Ltd (IBX.AX) reports a Gross Margin of 5.31%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Historical Trend of Imagion Biosystems Ltd's Gross Margin
Over recent years, Imagion Biosystems Ltd's Gross Margin has shown limited historical data. The table below summarizes the historical values:
| Date | Gross Margin |
|---|---|
| 2024-12-31 | 5.31% |
| 2023-12-31 | -17.92% |
This trend highlights how Imagion Biosystems Ltd manages its operational efficiency and pricing power over time.
Comparing Imagion Biosystems Ltd's Gross Margin to Peers
To better understand Imagion Biosystems Ltd's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| Imagion Biosystems Ltd (IBX.AX) | 5.31% |
| Simavita Ltd (SVA.AX) | 5584.01% |
| Silver Castle Holdings Ltd (ICB.TA) | 2512.20% |
| EMvision Medical Devices Ltd (EMV.AX) | 100.14% |
| Neurotech International Ltd (NTI.AX) | 100.00% |
| Vitasora Health Ltd (RSH.AX) | 99.63% |
Compared to its competitors, Imagion Biosystems Ltd's Gross Margin is among the lowest compared to peers, suggesting potential challenges in production costs or pricing strategy.